Open Access
,
volume 18
Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study
Alberto Papi
1
,
BRADLEY E. CHIPPS
2
,
Richard Beasley
3
,
Reynold A. Panettieri
4
,
Elliot Israel
5
,
Mark Cooper
6
,
Lynn Dunsire
6
,
Allison Jeynes-Ellis
7
,
Robert Rees
7
,
Frank C Albers
8
,
Christy Cappelletti
9
2
The Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA
|
5
7
Avillion, London, UK
|
8
Avillion, Northbrook, IL, USA
|
Publication type: Journal Article
Publication date: 2024-01-01
scimago Q1
wos Q2
SJR: 0.970
CiteScore: 4.7
Impact factor: 3.0
ISSN: 17534658, 17534666
PubMed ID:
38698565
Abstract
What is this summary about?
This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Journal of Asthma and Allergy
1 publication, 25%
|
|
|
Molecules
1 publication, 25%
|
|
|
The New England Journal of Medicine, Surgery and Collateral Branches of Science
1 publication, 25%
|
|
|
Annals of Allergy, Asthma and Immunology
1 publication, 25%
|
|
|
1
|
Publishers
|
1
|
|
|
Taylor & Francis
1 publication, 25%
|
|
|
MDPI
1 publication, 25%
|
|
|
Massachusetts Medical Society
1 publication, 25%
|
|
|
Elsevier
1 publication, 25%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4
Total citations:
4
Citations from 2024:
4
(100%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Papi A. et al. Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study // Therapeutic Advances in Respiratory Disease. 2024. Vol. 18.
GOST all authors (up to 50)
Copy
Papi A., CHIPPS B. E., Beasley R., Panettieri R. A., Israel E., Cooper M., Dunsire L., Jeynes-Ellis A., Rees R., Albers F. C., Cappelletti C. Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study // Therapeutic Advances in Respiratory Disease. 2024. Vol. 18.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1177/17534666241232264
UR - https://journals.sagepub.com/doi/10.1177/17534666241232264
TI - Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study
T2 - Therapeutic Advances in Respiratory Disease
AU - Papi, Alberto
AU - CHIPPS, BRADLEY E.
AU - Beasley, Richard
AU - Panettieri, Reynold A.
AU - Israel, Elliot
AU - Cooper, Mark
AU - Dunsire, Lynn
AU - Jeynes-Ellis, Allison
AU - Rees, Robert
AU - Albers, Frank C
AU - Cappelletti, Christy
PY - 2024
DA - 2024/01/01
PB - SAGE
VL - 18
PMID - 38698565
SN - 1753-4658
SN - 1753-4666
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2024_Papi,
author = {Alberto Papi and BRADLEY E. CHIPPS and Richard Beasley and Reynold A. Panettieri and Elliot Israel and Mark Cooper and Lynn Dunsire and Allison Jeynes-Ellis and Robert Rees and Frank C Albers and Christy Cappelletti},
title = {Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
volume = {18},
publisher = {SAGE},
month = {jan},
url = {https://journals.sagepub.com/doi/10.1177/17534666241232264},
doi = {10.1177/17534666241232264}
}
Profiles